Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

A. Moran; B. Bundy; D. J. Becker; L. A. DiMeglio; S. E. Gitelman; R. Goland; C. J. Greenbaum; K. C. Herold; J. B. Marks; P. Raskin; S. Sanda; D. Schatz; D. Wherrett; D. M. Wilson; J. P. Krischer; J. S. Skyler; L. Pickersgill; E. De Koning; A. G. Ziegler; B. Böehm; K. Badenhoop; N. Schloot; J. F. Bak; P. Pozzilli; D. Mauricio; M. Y. Donath; L. Castaño; A. Wägner; H. H. Lervang; H. Perrild; T. Mandrup-Poulsen

doi:10.1089/dia.2014.1510

Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

A. Moran, B. Bundy, D. J. Becker, L. A. DiMeglio, S. E. Gitelman, R. Goland, C. J. Greenbaum, K. C. Herold, J. B. Marks, P. Raskin, S. Sanda, D. Schatz, D. Wherrett, D. M. Wilson, J. P. Krischer, J. S. Skyler, L. Pickersgill, E. De Koning, A. G. Ziegler, B. BöehmK. Badenhoop, N. Schloot, J. F. Bak, P. Pozzilli, D. Mauricio, M. Y. Donath, L. Castaño, A. Wägner, H. H. Lervang, H. Perrild, T. Mandrup-Poulsen

Medicine

Research output: Contribution to journal › Comment/debate

Original language	English (US)
Pages (from-to)	S87
Journal	Diabetes Technology and Therapeutics
Volume	16
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1089/dia.2014.1510
State	Published - Feb 10 2014

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

Cite this

Moran, A., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Greenbaum, C. J., Herold, K. C., Marks, J. B., Raskin, P., Sanda, S., Schatz, D., Wherrett, D., Wilson, D. M., Krischer, J. P., Skyler, J. S., Pickersgill, L., De Koning, E., Ziegler, A. G., ... Mandrup-Poulsen, T. (2014). Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials. Diabetes Technology and Therapeutics, 16(SUPPL. 1), S87. https://doi.org/10.1089/dia.2014.1510

Interleukin-1 antagonism in type 1 diabetes of recent onset : Two multicenter, randomized double-masked, placebo-controlled trials. / Moran, A.; Bundy, B.; Becker, D. J.; DiMeglio, L. A.; Gitelman, S. E.; Goland, R.; Greenbaum, C. J.; Herold, K. C.; Marks, J. B.; Raskin, P.; Sanda, S.; Schatz, D.; Wherrett, D.; Wilson, D. M.; Krischer, J. P.; Skyler, J. S.; Pickersgill, L.; De Koning, E.; Ziegler, A. G.; Böehm, B.; Badenhoop, K.; Schloot, N.; Bak, J. F.; Pozzilli, P.; Mauricio, D.; Donath, M. Y.; Castaño, L.; Wägner, A.; Lervang, H. H.; Perrild, H.; Mandrup-Poulsen, T.

In: Diabetes Technology and Therapeutics, Vol. 16, No. SUPPL. 1, 10.02.2014, p. S87.

Research output: Contribution to journal › Comment/debate

Moran, A, Bundy, B, Becker, DJ, DiMeglio, LA, Gitelman, SE, Goland, R, Greenbaum, CJ, Herold, KC, Marks, JB, Raskin, P, Sanda, S, Schatz, D, Wherrett, D, Wilson, DM, Krischer, JP, Skyler, JS, Pickersgill, L, De Koning, E, Ziegler, AG, Böehm, B, Badenhoop, K, Schloot, N, Bak, JF, Pozzilli, P, Mauricio, D, Donath, MY, Castaño, L, Wägner, A, Lervang, HH, Perrild, H & Mandrup-Poulsen, T 2014, 'Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials', Diabetes Technology and Therapeutics, vol. 16, no. SUPPL. 1, pp. S87. https://doi.org/10.1089/dia.2014.1510

Moran, A. ; Bundy, B. ; Becker, D. J. ; DiMeglio, L. A. ; Gitelman, S. E. ; Goland, R. ; Greenbaum, C. J. ; Herold, K. C. ; Marks, J. B. ; Raskin, P. ; Sanda, S. ; Schatz, D. ; Wherrett, D. ; Wilson, D. M. ; Krischer, J. P. ; Skyler, J. S. ; Pickersgill, L. ; De Koning, E. ; Ziegler, A. G. ; Böehm, B. ; Badenhoop, K. ; Schloot, N. ; Bak, J. F. ; Pozzilli, P. ; Mauricio, D. ; Donath, M. Y. ; Castaño, L. ; Wägner, A. ; Lervang, H. H. ; Perrild, H. ; Mandrup-Poulsen, T. / Interleukin-1 antagonism in type 1 diabetes of recent onset : Two multicenter, randomized double-masked, placebo-controlled trials. In: Diabetes Technology and Therapeutics. 2014 ; Vol. 16, No. SUPPL. 1. pp. S87.

@article{74d9e49ea4734973a932031ab6ea94a3,

title = "Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials",

author = "A. Moran and B. Bundy and Becker, {D. J.} and DiMeglio, {L. A.} and Gitelman, {S. E.} and R. Goland and Greenbaum, {C. J.} and Herold, {K. C.} and Marks, {J. B.} and P. Raskin and S. Sanda and D. Schatz and D. Wherrett and Wilson, {D. M.} and Krischer, {J. P.} and Skyler, {J. S.} and L. Pickersgill and {De Koning}, E. and Ziegler, {A. G.} and B. B{\"o}ehm and K. Badenhoop and N. Schloot and Bak, {J. F.} and P. Pozzilli and D. Mauricio and Donath, {M. Y.} and L. Casta{\~n}o and A. W{\"a}gner and Lervang, {H. H.} and H. Perrild and T. Mandrup-Poulsen",

year = "2014",

month = feb

day = "10",

doi = "10.1089/dia.2014.1510",

language = "English (US)",

volume = "16",

pages = "S87",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Interleukin-1 antagonism in type 1 diabetes of recent onset

T2 - Two multicenter, randomized double-masked, placebo-controlled trials

AU - Moran, A.

AU - Bundy, B.

AU - Becker, D. J.

AU - DiMeglio, L. A.

AU - Gitelman, S. E.

AU - Goland, R.

AU - Greenbaum, C. J.

AU - Herold, K. C.

AU - Marks, J. B.

AU - Raskin, P.

AU - Sanda, S.

AU - Schatz, D.

AU - Wherrett, D.

AU - Wilson, D. M.

AU - Krischer, J. P.

AU - Skyler, J. S.

AU - Pickersgill, L.

AU - De Koning, E.

AU - Ziegler, A. G.

AU - Böehm, B.

AU - Badenhoop, K.

AU - Schloot, N.

AU - Bak, J. F.

AU - Pozzilli, P.

AU - Mauricio, D.

AU - Donath, M. Y.

AU - Castaño, L.

AU - Wägner, A.

AU - Lervang, H. H.

AU - Perrild, H.

AU - Mandrup-Poulsen, T.

PY - 2014/2/10

Y1 - 2014/2/10

UR - http://www.scopus.com/inward/record.url?scp=84893300757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893300757&partnerID=8YFLogxK

U2 - 10.1089/dia.2014.1510

DO - 10.1089/dia.2014.1510

M3 - Comment/debate

AN - SCOPUS:84893300757

VL - 16

SP - S87

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - SUPPL. 1

ER -

Access to Document

10.1089/dia.2014.1510